Oct 15 2025 COOT SEED SDOT PFAI RKDA CBUS VERI GNPX DTCK

Описание: Here are the top momentum stocks ready to outperform the market on October 15, 2025.

On Tuesday afternoon, President Trump accused China of deliberately halting soybean purchases, which he said harmed U.S. farmers.

The President stated the U S is considering terminating trade with China involving cooking oil.

This announcement caused soybean-related stocks to surge.

Australian Oilseeds. Nasdaq symbol C O O T.

Australian Oilseeds Holdings specializes in the production and sale of non-G M O oilseeds and food-grade oils.

Origin Agritech. Nasdaq symbol S E E D.

Origin Agritech is an agricultural biotechnology holding company focused on crop seed breeding, genetic improvement, and seed production.

Pinnacle Food Group. Nasdaq symbol P F A I.

Pinnacle Food Group provides hydroponic growing systems, environmental consulting, and farming-as-a-service subscriptions.

Arcadia Biosciences. Nasdaq symbol R K D A.

Arcadia Biosciences produces and markets plant-based health and wellness products, including Zola Coconut Water and non-G M O specialty wheat traits.

Cibus Inc. Nasdaq symbol C B U S.

Cibus Inc. is an agricultural technology company specializing in gene editing to develop high-performance plant traits for food crops.

Davis Commodities. Nasdaq symbol D T C K.

Davis Commodities Limited is a global agricultural trading company specializing in sugar, rice, and oil and fat products.

Sadot Group Inc. Nasdaq symbol S D O T.

Sadot Group operates in agri-commodity origination, trading, and farm operations.

The company focuses on sustainable solutions to address food security challenges in soybean meal, wheat, and corn.

Veritone Inc. Nasdaq symbol V E R I.

Veritone announced new contracts and strong preliminary Q 3 results.

The A I firm expects Q 3 revenue of 29 Million U S D. Up 31 percent year over year, and above analysts estimate.

Genprex Inc. Nasdaq symbol G N P X.

Genprex announced positive preclinical data on its lead drug candidate, Reqorsa® Gene Therapy.

The findings will be showcased in a poster session on October 25, 2025.